Release date: January 4, 2023
Expiration date: January 4, 2025
Estimated Time of Completion: 15 minutes
Description
Participate in this CME-certified, on demand online education that addresses pulmonary hypertension diagnosis and treatment, including the most recent advances and future directions in the diagnosis and management in the context of challenges faced by physicians and other health care providers caring for these patients.
Learning Objectives
- Describe metabolic changes that have been found in PAH.
- Discuss insulin resistance in PAH.
Target Audience
This course is designed for physicians, pharmacists, nurse practitioners, and nurses with an interest in pulmonary hypertension.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 0.25 ANCC contact hours.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Gustavo A. Heresi, MD
Section Head, Pulmonary Vascular Disease
Department of Pulmonary and Critical Care Medicine
Respiratory Institute
Cleveland Clinic
Cleveland, OH
Samar Farha, MD
Department of Pulmonary and Critical Care Medicine
Respiratory Institute
Cleveland Clinic
Cleveland, OH
Faculty
Anna Hemnes, MD
Associate Professor of Medicine
Pulmonary & Critical Care
Vanderbilt University Medical Center
Nashville, TN
Planning Committee
Mindy Rivera, CNS
Heather Torbic, PharmD
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Acknowledgment
The Cleveland Clinic Center for Continuing Education acknowledges educational grants for partial support of this Internet Enduring activity from:
Bayer HealthCare Pharmaceuticals Inc
Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson
Liquidia Technologies
United Therapeutics Corporation
The Cleveland Clinic Center for Continuing Education acknowledges educational grants for partial support of the Live activity from:
Bayer HealthCare Pharmaceuticals Inc
Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson
Liquidia Technologies
Merck Sharp & Dohme LLC
United Therapeutics Corporation
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Gustavo Heresi-Davila, MD |
| Bayer Healthcare |
Advisor or review panel participant
Teaching and Speaking |
| Janssen Research & Development, LLC |
Advisor or review panel participant |
| Anna R. Hemnes, MD |
| Actelion |
Consulting |
| United Therapeutics Corporation |
Consulting |
| Bayer |
Consulting |
| Merck & Co, Inc. |
Consulting |
| Janssen |
Consulting |
| Gossamer Bio |
Consulting |
| tenax therapeutics |
Ownership interest (stock, stock options in a publicly owned company) |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Samar Farha, MD
Mindy Rivera, CNS
Heather Torbic, PharmD
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education.
